INVESTORS & MEDIA
Corporate Governance
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| May 18, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
| May 18, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Other acquisition or disposition | -- | -- |
| May 17, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Open market or private sale of non-derivative or derivative security | 3,379 | $518.63 |
| May 17, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Open market or private sale of non-derivative or derivative security | 10,336 | $519.47 |
| May 17, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Open market or private sale of non-derivative or derivative security | 3,806 | $520.17 |
| May 14, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 40,000 | $179.13 |
| May 14, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 27,775 | $516.69 |
| May 14, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 12,500 | $52.03 |
| May 14, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 7,204 | $516.69 |
| May 14, 2021 |
EVP Research and Development
Trans History: 592
|
EVP Research and Development | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 12,500 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.